Mars Lennart T, Saikali Philippe, Liblau Roland S, Arbour Nathalie
INSERM, U563, Centre de Physiopathologie de Toulouse Purpan, Hôpital Purpan, Toulouse, F-31300, France; Université Toulouse III, Paul-Sabatier, Toulouse, F-31400, France.
Biochim Biophys Acta. 2011 Feb;1812(2):151-61. doi: 10.1016/j.bbadis.2010.07.006. Epub 2010 Jul 15.
Multiple sclerosis (MS) is an inflammatory disease of the central nervous system (CNS) characterized by multi-focal demyelination, axonal loss, and immune cell infiltration. Numerous immune mediators are detected within MS lesions, including CD4(+) and CD8(+) T lymphocytes suggesting that they participate in the related pathogenesis. Although CD4(+) T lymphocytes are traditionally considered the main actors in MS immunopathology, multiple lines of evidence suggest that CD8(+) T lymphocytes are also implicated in the pathogenesis. In this review, we outline the recent literature pertaining to the potential roles of CD8(+) T lymphocytes both in MS and its animal models. The CD8(+) T lymphocytes detected in MS lesions demonstrate characteristics of activated and clonally expanded cells supporting the notion that these cells actively contribute to the observed injury. Moreover, several experimental in vivo models mediated by CD8(+) T lymphocytes recapitulate important features of the human disease. Whether the CD8(+) T cells can induce or aggravate tissue destruction in the CNS needs to be fully explored. Strengthening our understanding of the pathogenic potential of CD8(+) T cells in MS should provide promising new avenues for the treatment of this disabling inflammatory disease.
多发性硬化症(MS)是一种中枢神经系统(CNS)的炎症性疾病,其特征为多灶性脱髓鞘、轴突丢失和免疫细胞浸润。在MS病灶中检测到多种免疫介质,包括CD4(+)和CD8(+) T淋巴细胞,提示它们参与了相关发病机制。虽然传统上认为CD4(+) T淋巴细胞是MS免疫病理学的主要参与者,但多项证据表明CD8(+) T淋巴细胞也与发病机制有关。在本综述中,我们概述了近期有关CD8(+) T淋巴细胞在MS及其动物模型中潜在作用的文献。在MS病灶中检测到的CD8(+) T淋巴细胞表现出活化和克隆扩增细胞的特征,支持这些细胞积极促成所观察到的损伤这一观点。此外,几种由CD8(+) T淋巴细胞介导的体内实验模型重现了人类疾病的重要特征。CD8(+) T细胞是否能诱导或加重CNS中的组织破坏尚需充分探索。加强我们对MS中CD8(+) T细胞致病潜力的理解应为治疗这种致残性炎症性疾病提供有前景的新途径。